chloroterpyridineplatinum(ii) has been researched along with Carcinoma, Epidermoid in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boeheim, K; Ervin, TJ; Holden, SA; Teicher, BA; Weichselbaum, RR | 1 |
1 other study(ies) available for chloroterpyridineplatinum(ii) and Carcinoma, Epidermoid
| Article | Year |
|---|---|
Platinum complexes inhibit repair of potentially lethal damage following bleomycin treatment.
Topics: Bleomycin; Carcinoma, Squamous Cell; Cell Line; Cell Survival; Cisplatin; Dose-Response Relationship, Drug; Head and Neck Neoplasms; Humans; Organoplatinum Compounds; Time Factors | 1987 |